1. Home
  2. TWLO vs KVUE Comparison

TWLO vs KVUE Comparison

Compare TWLO & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twilio Inc.

TWLO

Twilio Inc.

HOLD

Current Price

$204.08

Market Cap

30.1B

Sector

Technology

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$18.14

Market Cap

32.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWLO
KVUE
Founded
2008
2022
Country
United States
United States
Employees
5587
N/A
Industry
Computer Software: Prepackaged Software
Specialty Chemicals
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
30.1B
32.9B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
TWLO
KVUE
Price
$204.08
$18.14
Analyst Decision
Buy
Buy
Analyst Count
24
11
Target Price
$151.54
$19.45
AVG Volume (30 Days)
2.8M
18.2M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
4.82%
EPS Growth
N/A
40.74
EPS
N/A
0.25
Revenue
N/A
$15,124,000,000.00
Revenue This Year
$14.44
$4.85
Revenue Next Year
$8.21
$2.63
P/E Ratio
$526.76
$72.28
Revenue Growth
N/A
N/A
52 Week Low
$91.84
$14.02
52 Week High
$238.48
$22.87

Technical Indicators

Market Signals
Indicator
TWLO
KVUE
Relative Strength Index (RSI) 54.43 62.55
Support Level $111.06 $16.86
Resistance Level $238.48 $19.07
Average True Range (ATR) 13.89 0.37
MACD -2.55 0.10
Stochastic Oscillator 42.75 94.36

Price Performance

Historical Comparison
TWLO
KVUE

About TWLO Twilio Inc.

Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Share on Social Networks: